What is CARL's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.39B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for CARL?

P/E (TTM) is n/a and 52-week range is $8.50 to $17.23 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s CARL figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for CARL?

The company profile lists revenue (TTM) near $63M, net income (TTM) near $-3.63B, EPS (TTM) near $-1.44 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Carlsmed Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Carlsbad, California, US, 27.2M shares outstanding, ISIN US14280C1053 when available from company profile and filing metadata.

Carlsmed Inc

$CARL

Health Care · Health Care Equipment & Supplies

Run Scenarios

$14.42

+2.63%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. The company is headquartered in Carlsbad, California and currently employs 127 full-time employees. The company went IPO on 2025-07-23. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights for each surgeon. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.

Employees

127

Website

carlsmed.com/

IPO

2025-07-23

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)